NCT01973205

Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine

A Multi-center, Randomized, Double-blind, Parallel-group, Single-dose, Placebo-controlled Study Comparing the Efficacy and Safety of a Combination of Acetaminophen and Aspirin vs Placebo in the Acute Treatment of Migraine

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 900 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine

Conditions

• Acute Migraine

Interventions

Type	Name	Description
DRUG	Acetaminophen 250 mg and Aspirin 250 mg	2 tablets each containing Acetaminophen 250 mg and Aspirin 250 mg
DRUG	Placebo	2 placebo tablets matching acetaminophen 250 mg and aspirin 250 mg tablets

Timeline

• Start date: 2013-10-01
• Primary completion: 2014-07-01
• Completion: 2014-07-01
• First posted: 2013-10-31
• Last updated: 2015-06-11
• Results posted: 2015-06-11

Locations

19 sites across 1 country: United States